Growth Metrics

Mannkind (MNKD) EPS (Basic) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -225.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -225.00%
Dec 31, 2025 -266.67%
Sep 30, 2025 -25.00%
Jun 30, 2025 121.96%
Mar 31, 2025 0.00%
Dec 31, 2024 200.00%
Sep 30, 2024 300.00%
Jun 30, 2024 50.00%
Mar 31, 2024 200.00%
Dec 31, 2023 114.29%
Sep 30, 2023 116.67%
Jun 30, 2023 81.82%
Mar 31, 2023 60.00%
Dec 31, 2022 36.36%
Sep 30, 2022 -200.00%
Jun 30, 2022 21.43%
Mar 31, 2022 -100.00%
Dec 31, 2021 8.33%
Sep 30, 2021 60.00%
Jun 30, 2021 -180.00%
Mar 31, 2021 -25.00%
Dec 31, 2020 -71.43%
Sep 30, 2020 0.00%
Jun 30, 2020 28.57%
Mar 31, 2020 50.00%
Dec 31, 2019 -16.67%
Sep 30, 2019 68.75%
Jun 30, 2019 56.25%
Mar 31, 2019 68.00%
Dec 31, 2018 78.57%
Sep 30, 2018 48.39%
Jun 30, 2018 54.29%
Mar 31, 2018 -47.06%
Dec 31, 2017 -150.00%
Sep 30, 2017 -123.48%
Jun 30, 2017 -6.06%
Mar 31, 2017 41.38%
Dec 31, 2016 184.85%
Sep 30, 2016 438.46%
Jun 30, 2016 8.33%
Mar 31, 2016 -262.50%
Dec 31, 2015 -633.33%
Sep 30, 2015 -333.33%
Jun 30, 2015 -89.47%
Mar 31, 2015 42.86%
Dec 31, 2014 43.75%
Sep 30, 2014 47.06%
Jun 30, 2014 -18.75%
Mar 31, 2014 6.67%
Dec 31, 2013 30.43%
Sep 30, 2013 22.73%
Jun 30, 2013 30.43%
Mar 31, 2013 44.44%
Dec 31, 2012 23.33%
Sep 30, 2012 29.03%
Jun 30, 2012 37.84%
Mar 31, 2012 20.59%
Dec 31, 2011 9.09%
Sep 30, 2011 22.50%
Jun 30, 2011 0.00%